{"id":"W4386905499","doi":"10.14740/wjon1604","title":"Folfirinox vs. Gemcitabine + Nab-Paclitaxel as the First-Line Treatment for Pancreatic Cancer: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"World Journal of Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gemcitabine; FOLFIRINOX; Internal medicine; Confidence interval; Hazard ratio; Retrospective cohort study; Neutropenia; Pancreatic cancer; Odds ratio; Anemia; Diarrhea; Oncology; Gastroenterology; Surgery; Chemotherapy; Cancer; Irinotecan","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0102198,0.002599556,0.01899104,0.006899762,0.0005446593,0.002968761,0.002070918,0.001987423,0.003416417],"category_scores_gemma":[0.01940723,0.001193192,0.03270257,0.007374418,0.0005684377,0.001537504,0.001258146,0.001534298,0.0003289397],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002760329,"about_ca_system_score_gemma":0.003356227,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006053556,"about_ca_topic_score_gemma":0.01339036,"domain_scores_codex":[0.9936971,0.002901034,0.001779797,0.0006616299,0.0007267747,0.0002336595],"domain_scores_gemma":[0.9860352,0.01015651,0.002397556,0.0002849358,0.0009128579,0.0002129639],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002020967,0.00002994834,0.002466918,0.4626121,0.519851,0.0001168436,0.00006909727,0.000479728,0.000196804,0.0001267334,0.0005017826,0.01152808],"study_design_scores_gemma":[0.0004669362,0.0002013542,0.002265647,0.02708049,0.9681245,0.0000761004,0.00003457937,0.000158004,0.00007984912,0.0001280183,0.001367341,0.00001709067],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003748895,0.9948199,0.0003171953,0.0001552886,0.00009805488,0.0002173379,0.0004222506,0.00001687046,0.000204145],"genre_scores_gemma":[0.1306324,0.864695,0.00151369,0.0008355491,0.0002163142,0.0008855031,0.0008546571,0.00002594819,0.0003409903],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01899104,"threshold_uncertainty_score":0.05404812,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2444385207205781,"score_gpt":0.4941930577811587,"score_spread":0.2497545370605806,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}